Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused ...

A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month.

By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...

Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid ...

A paper published in Nature Communications says that scientists at the Peter Doherty Institute for Infection and Immunity in ...

Gilead’s HIV treatment trials involving an investigational integrase strand inhibitor (GS-1720) and an investigational capsid inhibitor (GS-4182) have been put on clinical hold by the Food and Drug ...

Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.

Nova Scotia physicians and other sexual health experts are calling on the provincial government to fund birth control and increase access to a medication used to prevent HIV.

A UVa researcher has discovered that NRTIs, drugs used to treat HIV, can also help prevent Alzheimer's and a long list of ...